DRUGS OF ABUSE FOR HOME USE
Several rapid tests for drugs of Abuse detection (one drug/test) are now available for home use: Cannabinoid, cocaine, opiates, amphetamines, […]
Compliance with
European regulations
Distribution in
170 + countries
ISO 13485
certified company
POC European
leader
New products
Read more
DUO RSV-INFLUENZA A+B-CHECK-1
Immunochromatographic rapid test for the qualitative detection of respiratory syncytial virus (RSV) and influenza A and B viruses in nasal […]
CALPROTECTIN’ALERT
Home use rapid test for the detection of faecal calprotectin associated to intestinal inflammation. This test is now CE marked. […]
COVID-19-CHECK-1 ANTIGEN FOR HOME USE
Self-testing rapid test for the qualitative detection of the SARS-CoV-2 virus in nasal swab samples in case of suspected covid-19 […]
COVID-19-CHECK-1 ANTIGEN
Immunochromatographic rapid test for the qualitative detection of SARS-CoV-2 virus in nasopharyngeal swab samples. The COVID-19-CHECK-1 Antigen test is a […]
Exhibition
AACC EXHIBITION
We are pleased to inform you that we will exhibit at AACC exhibition from July 25th to 27th, 2023 in […]
Information
Syphilis Health Check
The Syphilis Health Check test manufactured by VEDALAB has been granted by FDA on December 15th, 2014 the first-ever CLIA […]
Ebola Rapid Test
VedaLab is very proud to announce that, in collaboration with the CEA (Commissariat à l’Energie Atomique), its very reputable R&D […]
VEDALAB is a privately owned French company, founded in 1991.
VEDALAB is devoted to the development, production and marketing of in vitro immunodiagnostic rapid tests. As a market leader, VEDALAB focuses on international expansion by forming long-term partnerships with reliable and trustworthy distributors worldwide. Continually expanding its already broad range of products, VEDALAB is as of today the biggest real manufacturer of rapid tests in Europe.
Learn more